Logo image of INST

Instructure Holdings Inc (INST) Stock Fundamental Analysis

NYSE:INST - New York Stock Exchange, Inc. - US4577901030 - Common Stock - Currency: USD

23.6  +0.02 (+0.08%)

After market: 25 +1.4 (+5.93%)

Fundamental Rating

3

INST gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. INST has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, INST is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year INST was profitable.
In the past year INST had a positive cash flow from operations.
INST had negative earnings in each of the past 5 years.
INST had a positive operating cash flow in 4 of the past 5 years.
INST Yearly Net Income VS EBIT VS OCF VS FCFINST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

INST's Return On Assets of -1.80% is in line compared to the rest of the industry. INST outperforms 57.14% of its industry peers.
Looking at the Return On Equity, with a value of -4.19%, INST is in line with its industry, outperforming 57.50% of the companies in the same industry.
INST's Return On Invested Capital of 1.27% is fine compared to the rest of the industry. INST outperforms 66.07% of its industry peers.
Industry RankSector Rank
ROA -1.8%
ROE -4.19%
ROIC 1.27%
ROA(3y)-2.44%
ROA(5y)-7.63%
ROE(3y)-4.1%
ROE(5y)-17.24%
ROIC(3y)N/A
ROIC(5y)N/A
INST Yearly ROA, ROE, ROICINST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

INST has a better Operating Margin (6.68%) than 73.57% of its industry peers.
INST has a Gross Margin (66.28%) which is comparable to the rest of the industry.
INST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.68%
PM (TTM) N/A
GM 66.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.8%
GM growth 5Y-1.48%
INST Yearly Profit, Operating, Gross MarginsINST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

1

2. Health

2.1 Basic Checks

INST has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, INST has more shares outstanding
INST has more shares outstanding than it did 5 years ago.
INST has a better debt/assets ratio than last year.
INST Yearly Shares OutstandingINST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
INST Yearly Total Debt VS Total AssetsINST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

INST has an Altman-Z score of 1.28. This is a bad value and indicates that INST is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.28, INST is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
The Debt to FCF ratio of INST is 10.83, which is on the high side as it means it would take INST, 10.83 years of fcf income to pay off all of its debts.
INST has a Debt to FCF ratio (10.83) which is in line with its industry peers.
A Debt/Equity ratio of 0.90 indicates that INST is somewhat dependend on debt financing.
INST's Debt to Equity ratio of 0.90 is on the low side compared to the rest of the industry. INST is outperformed by 74.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 10.83
Altman-Z 1.28
ROIC/WACC0.11
WACC12.02%
INST Yearly LT Debt VS Equity VS FCFINST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

INST has a Current Ratio of 0.92. This is a bad value and indicates that INST is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of INST (0.92) is worse than 77.86% of its industry peers.
INST has a Quick Ratio of 0.92. This is a bad value and indicates that INST is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of INST (0.92) is worse than 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92
INST Yearly Current Assets VS Current LiabilitesINST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.64% over the past year.
The Revenue has grown by 11.58% in the past year. This is quite good.
Measured over the past years, INST shows a very strong growth in Revenue. The Revenue has been growing by 20.41% on average per year.
EPS 1Y (TTM)9.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
Revenue 1Y (TTM)11.58%
Revenue growth 3Y20.62%
Revenue growth 5Y20.41%
Sales Q2Q%28.34%

3.2 Future

INST is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.25% yearly.
INST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.05% yearly.
EPS Next Y0.86%
EPS Next 2Y4.72%
EPS Next 3Y7.25%
EPS Next 5YN/A
Revenue Next Year25.44%
Revenue Next 2Y17.22%
Revenue Next 3Y14.05%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
INST Yearly Revenue VS EstimatesINST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
INST Yearly EPS VS EstimatesINST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.93, which means the current valuation is very expensive for INST.
Compared to the rest of the industry, the Price/Earnings ratio of INST indicates a somewhat cheap valuation: INST is cheaper than 77.50% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.55. INST is around the same levels.
Based on the Price/Forward Earnings ratio of 25.02, the valuation of INST can be described as expensive.
74.64% of the companies in the same industry are more expensive than INST, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of INST to the average of the S&P500 Index (22.40), we can say INST is valued inline with the index average.
Industry RankSector Rank
PE 25.93
Fwd PE 25.02
INST Price Earnings VS Forward Price EarningsINST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, INST is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INST indicates a somewhat cheap valuation: INST is cheaper than 77.14% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 30.89
EV/EBITDA 22.44
INST Per share dataINST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates INST does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)30.19
PEG (5Y)N/A
EPS Next 2Y4.72%
EPS Next 3Y7.25%

0

5. Dividend

5.1 Amount

INST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Instructure Holdings Inc

NYSE:INST (11/12/2024, 8:11:18 PM)

After market: 25 +1.4 (+5.93%)

23.6

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-08 2024-11-08/amc
Earnings (Next)N/A N/A
Inst Owners98.16%
Inst Owner Change-91.04%
Ins Owners6.07%
Ins Owner Change0%
Market Cap3.47B
Analysts52.31
Price Target24.21 (2.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.76%
Min EPS beat(2)15.15%
Max EPS beat(2)46.37%
EPS beat(4)3
Avg EPS beat(4)20.51%
Min EPS beat(4)-0.74%
Max EPS beat(4)46.37%
EPS beat(8)5
Avg EPS beat(8)9.19%
EPS beat(12)9
Avg EPS beat(12)20.77%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)0%
Revenue beat(4)0
Avg Revenue beat(4)-0.74%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)0%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)6
Avg Revenue beat(12)0.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.56%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)0.19%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 25.93
Fwd PE 25.02
P/S 5.82
P/FCF 30.89
P/OCF 29.13
P/B 2.73
P/tB N/A
EV/EBITDA 22.44
EPS(TTM)0.91
EY3.86%
EPS(NY)0.94
Fwd EY4%
FCF(TTM)0.76
FCFY3.24%
OCF(TTM)0.81
OCFY3.43%
SpS4.05
BVpS8.65
TBVpS-8.15
PEG (NY)30.19
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.8%
ROE -4.19%
ROCE 1.6%
ROIC 1.27%
ROICexc 1.34%
ROICexgc N/A
OM 6.68%
PM (TTM) N/A
GM 66.28%
FCFM 18.85%
ROA(3y)-2.44%
ROA(5y)-7.63%
ROE(3y)-4.1%
ROE(5y)-17.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.8%
GM growth 5Y-1.48%
F-Score4
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 10.83
Debt/EBITDA 5.62
Cap/Depr 4.17%
Cap/Sales 1.14%
Interest Coverage 0.61
Cash Conversion 58.77%
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 1.28
F-Score4
WACC12.02%
ROIC/WACC0.11
Cap/Depr(3y)3.87%
Cap/Depr(5y)13.03%
Cap/Sales(3y)1.17%
Cap/Sales(5y)1.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
EPS Next Y0.86%
EPS Next 2Y4.72%
EPS Next 3Y7.25%
EPS Next 5YN/A
Revenue 1Y (TTM)11.58%
Revenue growth 3Y20.62%
Revenue growth 5Y20.41%
Sales Q2Q%28.34%
Revenue Next Year25.44%
Revenue Next 2Y17.22%
Revenue Next 3Y14.05%
Revenue Next 5YN/A
EBIT growth 1Y477.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.52%
EBIT Next 3Y16.91%
EBIT Next 5YN/A
FCF growth 1Y19.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.16%
OCF growth 3YN/A
OCF growth 5Y339.52%